Entity family
Named questionnaires, scales, scores, indices, and other clinical outcome assessments. Examples include PHQ-9, GAD-7, EQ-5D.
This clinical instrument is selected. Its supporting articles are shown below.
…on of adverse cardiovascular disease (CVD) risk using CT-CAD to QRISK®3 (a well-established UK CVD risk score); Assess current prescr…
…nomic deprivation, and retrospectively evaluated the ability of QRISK3 and lipid profile to predict the subsequent event.Methods Study…
…early detection is essential for the primary prevention of CAD. QRISK3 is known to overestimate future CAD risk in some populations, r…
…d in 62.5% of patients, at a median dose of 2.5 mg/day (IQR 5). QRISK3 classified 44.1% of patients as high risk, compared with 22.8% …
…o, we have showed statistically significant correlation between QRISK3 and risk factors such as smoking and HTA, as well as: age, dise…
…ents with/without depression and documentation of a high global QRISK risk score (HQR) were included. Outcome variables were LLT pres…
…rmance of the main CV risk calculators, Framingham Score (FRS), QRISK3, and SLECRE,2 in predicting CV events at 10 years.Methods We en…
…cular health lifestyle advice; to determine whether age, sex or QRISK3 cardiovascular risk score influences statin prescription; to id…
…±22 mmHg, respectively. Median follow-up was 428 (313–486) days.QRISK3 score had not been calculated for any of these patients. Electr…
…oal was to identify individuals with elevated 10-year CVD risk (QRISK3 ≥10%) and those eligible for targeted interventions such as wei…
… the appropriate threshold, and the percentage of patients with QRISK >20% treated with lipid-lowering therapy (LLT). The data are pu…
…y care. The value of (often complex) prediction models (such as QRISK cardiovascular risk scores8) in primary care to aid decision ma…